Ko Wen-Je, Lin Ching-Yuang, Chen Robert J, Wang Shoei-Shen, Lin Fang-Yue, Chen Yih-Sharng
Department of Surgery, National Taiwan University Hospital, Taipei.
Ann Thorac Surg. 2002 Feb;73(2):538-45. doi: 10.1016/s0003-4975(01)03330-6.
Postcardiotomy cardiogenic shock occasionally develops in patients who have undergone cardiac procedures. We report our experience using extracorporeal membrane oxygenation (ECMO) in adult patients with postcardiotomy cardiogenic shock, and analyze the factors that affected outcomes for these ECMO patients.
We retrospectively reviewed the medical records of ECMO patients.
From August 1994 to May 2000, 76 adult patients (48 men, 28 women; mean age, 56.8+/-15.9 years) received ECMO support for postcardiotomy cardiogenic shock at the National Taiwan University Hospital. The mean ECMO blood flow was 2.53+/-0.84 L/min. The cardiac operations included coronary artery bypass grafting (n = 37), coronary artery bypass grafting and valvular operation (n = 6), valvular operation alone (n = 14), heart transplantation (n = 12), correction of congenital heart defects (n = 3), implantation of a left ventricular assist device (n = 2), and aortic operations (n = 2). Fifty-four patients received ECMO support after intraaortic balloon pumping, but 22 patients directly received ECMO support. Two patients were bridged to heart transplantation and two bridged to ventricular assist devices. Thirty patients died on ECMO support. The causes of mortality included brain death (n = 3), refractory arrhythmia (n = 2), near motionless heart (n = 2), acute graft rejection (n = 1), primary graft failure (n = 1), uncontrolled bleeding (n = 5), and multiple organ failure (n = 16). Twenty-two patients were weaned off ECMO support but presented intrahospital mortality. The cause of mortality included brain death (n = 1), sudden death (n = 4), and multiple organ failure (n = 17). Twenty patients were weaned off ECMO support and survived to hospital discharge. During the follow-up of 33+/-22 months, all were in New York Heart Association functional status I or II except two cases of late deaths. Among the ECMO-weaned patients, "dialysis for acute renal failure" was a significant factor in reducing the chance of survival.
The ECMO provided a satisfactory partial cardiopulmonary support to patients with postcardiotomy cardiogenic shock, and allowed time for clinicians to assess the patients and make appropriate decisions.
心脏手术后的心源性休克偶尔会在接受心脏手术的患者中发生。我们报告了我们在成年心脏手术后心源性休克患者中使用体外膜肺氧合(ECMO)的经验,并分析了影响这些接受ECMO治疗患者预后的因素。
我们回顾性地查阅了接受ECMO治疗患者的病历。
1994年8月至2000年5月,76例成年患者(48例男性,28例女性;平均年龄56.8±15.9岁)在台湾大学医院接受了ECMO支持以治疗心脏手术后的心源性休克。平均ECMO血流量为2.53±0.84L/分钟。心脏手术包括冠状动脉搭桥术(n = 37)、冠状动脉搭桥术和瓣膜手术(n = 6)、单纯瓣膜手术(n = 14)、心脏移植(n = 12)、先天性心脏缺陷矫正术(n = 3)、左心室辅助装置植入术(n = 2)和主动脉手术(n = 2)。54例患者在主动脉内球囊反搏后接受了ECMO支持,但22例患者直接接受了ECMO支持。2例患者过渡到心脏移植,2例过渡到心室辅助装置。30例患者在接受ECMO支持期间死亡。死亡原因包括脑死亡(n = 3)、难治性心律失常(n = 2)、心脏几乎停搏(n = 2)、急性移植排斥反应(n = 1)、原发性移植失败(n = 1)、无法控制的出血(n = 5)和多器官功能衰竭(n = 16)。22例患者撤掉了ECMO支持,但出现了院内死亡。死亡原因包括脑死亡(n = 1)、猝死(n = 4)和多器官功能衰竭(n = 17)。20例患者撤掉了ECMO支持并存活至出院。在33±22个月的随访期间,除2例晚期死亡病例外,所有患者的纽约心脏协会心功能分级均为I级或II级。在撤掉ECMO的患者中,“因急性肾衰竭进行透析”是降低生存机会的一个重要因素。
ECMO为心脏手术后的心源性休克患者提供了令人满意的部分心肺支持,并为临床医生评估患者和做出适当决策留出了时间。